Table 2.
Adenocarcinoma | Squamous Cell Carcinoma | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Relapse | Relapse | |||||||||||
No | Yes | No | Yes | |||||||||
Number (%) | Number (%) | P-value a | HR (95% CI) b | P-value | Number (%) | Number (%) | P-value a | HR (95% CI) b | P-value | |||
Univariate | Univariate | |||||||||||
PD1 <= 0.88 | 92 (66.19) | 47 (33.81) | 0.0228 | Ref. | PD1 <= 1.59 | 46 (62.16) | 28 (37.84) | 0.0311 | Ref. | |||
PD1 > 0.88 | 195 (77.38) | 57 (22.62) | 0.62 (0.41 ~ 0.93) | 0.0201 | PD1 > 1.59 | 23 (85.19) | 4 (14.81) | 0.32 (0.11 ~ 0.96) | 0.0423 | |||
PDL1 <= 0.93 | 49 (62.82) | 29 (37.18) | 0.0220 | Ref. | PDL1 <= 1.20 | 26 (57.78) | 19 (42.22) | 0.0534 | Ref. | |||
PDL1 > 0.93 | 238 (76.04) | 75 (23.96) | 0.63 (0.39 ~ 1.00) | 0.0514 | PDL1 > 1.20 | 43 (76.79) | 13 (23.21) | 0.45 (0.21 ~ 0.95) | 0.0359 | |||
Additive model c | 0.69 (0.53 ~ 0.91) | 0.0076 | Additive model c | 0.53 (0.32 ~ 0.89) | 0.0155 | |||||||
Number of higher expression PD1/PDL1 | Number of higher expression PD1/PDL1 | |||||||||||
0 higher expression gene | 31 (55.36) | 25 (44.64) | 0.0055 | Ref. | 0 higher expression gene | 26 (57.78) | 19 (42.22) | 0.0522 | Ref. | |||
1 higher expression gene | 79 (75.24) | 26 (24.76) | 0.51 (0.28 ~ 0.92) | 0.0245 | 1 higher expression gene | 20 (68.97) | 9 (31.03) | 0.61 (0.27 ~ 1.37) | 0.2349 | |||
2 higher expression gene | 177 (76.96) | 53 (23.04) | 0.44 (0.26 ~ 0.75) | 0.0025 | 2 higher expression gene | 23 (85.19) | 4 (14.81) | 0.26 (0.08 ~ 0.81) | 0.0207 | |||
Outcomes | Outcomes | |||||||||||
Alive | Dead | Alive | Dead | |||||||||
Number (%) | Number (%) | P-value a | HR (95% CI) b | P-value | Number (%) | Number (%) | P-value a | HR (95% CI) b | P-value | |||
Univariate | Univariate | |||||||||||
PD1 <= 0.88 | 103 (61.31) | 65 (38.69) | 0.0074 | Ref. | PD1 <= 1.59 | 35 (35.71) | 63 (64.29) | 0.5017 | Ref. | |||
PD1 > 0.88 | 193 (73.95) | 68 (26.05) | 0.58 (0.41 ~ 0.82) | 0.0023 | PD1 > 1.59 | 12 (44.44) | 15 (55.56) | 0.63 (0.34 ~ 1.16) | 0.1361 | |||
PDL1 <= 0.93 | 65 (60.75) | 42 (39.25) | 0.0401 | Ref. | PDL1 <= 1.20 | 25 (36.76) | 43 (63.24) | 0.8548 | Ref. | |||
PDL1 > 0.93 | 231 (71.74) | 91 (28.26) | 0.61 (0.42 ~ 0.89) | 0.0101 | PDL1 > 1.20 | 22 (38.60) | 35 (61.40) | 0.73 (0.45 ~ 1.18) | 0.1937 | |||
Additive model c | 0.68 (0.54 ~ 0.84) | 0.0005 | Additive model c | 0.78 (0.57 ~ 1.00) | 0.0539 | |||||||
Number of higher expression PD1/PDL1 | Number of higher expression PD1/PDL1 | |||||||||||
0 higher expression gene | 42 (53.85) | 36 (46.15) | 0.0062 | Ref. | 0 higher expression gene | 25 (36.76) | 43 (63.24) | 0.6839 | Ref. | |||
1 higher expression gene | 84 (70.59) | 35 (29.41) | 0.49 (0.30 ~ 0.79) | 0.0032 | 1 higher expression gene | 10 (33.33) | 20 (66.67) | 0.85 (0.49 ~ 1.45) | 0.5425 | |||
2 higher expression gene | 170 (73.28) | 62 (26.72) | 0.43 (0.28 ~ 0.66) | 0.0001 | 2 higher expression gene | 12 (44.44) | 15 (55.56) | 0.59 (0.31 ~ 1.12) | 0.1068 |
HR, Hazard ratio; CI, confidence interval; Ref., reference group.
P-value for Fisher exact test.
Adjusted for age and gender.
Trend test for additive model.
Bold face: statistically significant (P value<0.05).